Product Information

SAPHRIS 10 MG TAB SUBLINGUAL is a brand product labeled by Allergan, Inc., priced at $21.1603 per EA under NDC 00456241060. Its NADAC has been published 610 times since Dec 17, 2014.

FDA first approved this application on Aug 13, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SAPHRIS 10 MG TAB SUBLINGUAL

Asenapine Maleate
$21.1603per EA

Strength

10 mg/1

Manufacturer

Allergan, Inc.

NDC

00456241060

Classification

Brand

Dosage Form

TABLET

Route

SUBLINGUAL

Effective Date

8/19/2026

Active Ingredients

ASENAPINE MALEATE

Approval Type

New Drug (NDA)

FDA Application

NDA022117

FDA Approved

8/13/2009

TE Code

AB

On Market Since

9/30/2013

Pharmacological Classes

Price Statistics

The NADAC for SAPHRIS 10 MG TAB SUBLINGUAL has been published 610 times since Dec 17, 2014, and over the history we have for it it has risen 73.0%. The table below summarizes its recorded NADAC range and movement.

Current price$21.1603 per EA
All-time high$21.2006 (Jun 10, 2026)
All-time low$12.2292 (Dec 17, 2014)
52-week high$21.2006
52-week low$20.1787
Median price$19.1636
Average price$18.4200
Largest weekly change+9.9% (Oct 7, 2015)
Weeks tracked610
Tracking sinceDec 17, 2014

Price History

1W

+0.0%

1M

+0.0%

3M

-0.2%

6M

-0.2%

1Y

+4.8%

3Y

+10.1%

5Y

+10.6%

All

+73.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Asenapine Maleate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of SAPHRIS 10 MG TAB SUBLINGUAL?

The current National Average Drug Acquisition Cost (NADAC) for SAPHRIS 10 MG TAB SUBLINGUAL, manufactured by Allergan, Inc., is $21.1603 per EA (NDC 00456241060), effective Aug 19, 2026.

How has the price of SAPHRIS 10 MG TAB SUBLINGUAL changed over time?

Over the history we have for it, the NADAC for SAPHRIS 10 MG TAB SUBLINGUAL has risen 73.0%. It has been tracked across 610 weekly CMS publications since Dec 17, 2014.

What are the highest and lowest recorded NADAC prices for SAPHRIS 10 MG TAB SUBLINGUAL?

Since Dec 17, 2014, the NADAC for SAPHRIS 10 MG TAB SUBLINGUAL has ranged from a low of $12.2292 (Dec 17, 2014) to a high of $21.2006 (Jun 10, 2026), with a median of $19.1636 per EA.

Are there cheaper alternatives to SAPHRIS 10 MG TAB SUBLINGUAL?

No other NADAC-published product currently shares the active ingredient and strength of SAPHRIS 10 MG TAB SUBLINGUAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SAPHRIS 10 MG TAB SUBLINGUAL?

SAPHRIS 10 MG TAB SUBLINGUAL (NDC 00456241060) is labeled by Allergan, Inc., and CMS classifies it as a brand product.